May 23rd 2025, 3:00pm
GLP-1 drugs lowered rates of obesity-related cancers and death versus DPP-4s, with no increased cancer risk, study finds.
May 22nd 2025, 9:00pm
Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
Among patients with ES-SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.
June 17th 2024, 3:00pm
Data show that patients’ multiple myeloma still fails to progress if patients receive less-frequent Tecvayli.
June 15th 2024, 2:00pm
To ensure best outcomes, patients with chronic myeloid leukemia should maintain frequent communication with their care teams — even between appointments.
June 14th 2024, 10:00pm
Most — though not all — side effects from chronic myeloid leukemia treatment improve over time, an expert said.
June 14th 2024, 9:00pm
A chronic myeloid leukemia diagnosis can negatively affect patients and their loved ones’ mental health, but there are resources that can help.
June 13th 2024, 9:00pm
Patients with chronic myeloid leukemia should be upfront with their care team about how treatment side effects are affecting their daily functioning.
June 13th 2024, 1:00pm
Initial discussions about treatment, side effects and study results can help patients navigate through all aspects of a chronic myeloid leukemia diagnosis.
June 12th 2024, 8:00pm
An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.
Uniting Pediatric and Adult Oncologists to Advance AYA Lymphoma Care
Making Something Positive out of Breast Cancer
Ovarian Cancer Treatment Side Effects Make for a Difficult Balancing Act
GLP-1 Drugs Linked to Fewer Obesity-Related Cancers